A study reported that glycyrrhetic acid (10, 50 mg/kg) could decrease the levels of IL-6, IL-1β, and TNF-α, and suppress the expression of COX-2, NF-κB, and PGE2 protein for treating the DSS-induced colitis mice (Jeon et al., 2016b). Here, IL1B is linked to colitis.